Solution structure of the X4 protein coded by the SARS related coronavirus reveals an immunoglobulin like fold and suggests a binding activity to integrin I domains

Journal of Biomedical Science

Volumn 13, Issue 3, 2006, Pages 281-293

  Hänel, Karen ^a,b   Stangler, Thomas ^a,b   Stoldt, Matthias ^a,b   Willbold, Dieter ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

7a; Coronavirus; Immunoglobulin fold; Integrin; LFA 1; Nmr structure determination; ORF8; SARS; U122; X4

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN; INTEGRIN; INTEGRIN I; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; PROTEIN 7A; PROTEIN U122; PROTEIN X4; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CORONAVIRUS; DATA BASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORF7A GENE; ORF8 GENE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; SARS CORONAVIRUS; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANTIGENS, CD; CELL ADHESION MOLECULES; CLONING, MOLECULAR; HUMANS; IMMUNOGLOBULINS; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SARS VIRUS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

CORONAVIRUS;

EID: 33646549605     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9043-9     Document Type: Article

References (48)

1. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J. and Bellini W.J., Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394-1399, 2003.
2. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C. and Roper R.L., The Genome sequence of the SARS-associated coronavirus. Science 300: 1399-1404, 2003.
3. Stadler K., Masignani V., Eickmann M., Becker S., Abrignani S., Klenk H.D. and Rappuoli R., SARS - beginning to understand a new virus. Nat. Rev. Microbiol. 1: 209-218, 2003.
4. Steffens C.M. and Hope T.J., Recent advances in the understanding of HIV accessory protein function. Aids 15(Suppl 5) S21-S26, 2001.
5. Bour S. and Strebel K., The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release. Microbes Infect. 5: 1029-1039, 2003.
6. Stockl J., Vetr H., Majdic O., Zlabinger G., Kuechler E. and Knapp W., Human major group rhino viruses down-modulate the accessory function of monocytes by inducing IL-10. J. Clin. Invest. 104: 957-965, 1999.
7. Nelson C.A., Pekosz A., Lee C.A., Diamond M.S. and Fremont D.H., Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure 13: 75-85, 2005.
8. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J., Poon L.L., Guan Y., Rozanov M., Spaan W.J. and Gorbalenya A.E., Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331: 991-1004, 2003.
9. Fielding B.C., Tan Y.J., Shuo S., Tan T.H., Ooi E.E., Lim S.G., Hong W. and Goh P.Y., Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirus. J. Virol. 78: 7311-7318, 2004.
10. Tan Y.J., Teng E., Shen S., Tan T.H., Goh P.Y., Fielding B.C., Ooi E.E., Tan H.C., Lim S.G. and Hong W., A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. J. Virol. 78: 6723-6734, 2004.
11. Yu C.J., Chen Y.C., Hsiao C.H., Kuo T.C., Chang S.C., Lu C.Y., Wei W.C., Lee C.H., Huang L.M., Chang M.F., Ho H.N. and Lee F.J., Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus. FEBS Lett. 565: 111-116, 2004.
12. Tan Y.J., Fielding B.C., Goh P.Y., Shen S., Tan T.H., Lim S.G. and Hong W., Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J. Virol. 78: 14043-14047, 2004.
13. Maniatis T., Fritsch E.F. and Sambrook J., Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory, NY, 1982.
14. Farrow N.A., Muhandiran R., Singer A.U., Pascal S.M., Kay C.M., Gish G., Shoelson S.E., Pawson T., Forman-Kay J.D. and Kay L.E., Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMRrelaxation. Biochemistry 33: 5984-6003, 1994.
15. Keller R., Computer Aided Resonance Assignment Tutorial, 1st ed.,. Cantina Verlag, , 2004.
16. Nilges M. and O'Donoghue S.I., Ambiguous NOEs and automated NOE assignment. Progr. Nucl. Magn. Res. Spectr. 32: 107-139, 1998.
17. Nilges M., A calculation strategy for the structure determination of symmetric dimers by 1H NMR. Proteins 17: 297-309, 1993.
18. Koradi R., Billeter M. and Wuthrich K., MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55, 1996.
19. Laskowski R.A., Rullmann J.A.C., MacArthur M.W., Kaptein R. and Thornton J.M., AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8: 477-486, 1996.
20. Vriend G., What If - a molecular modeling and drug design program. J. Mol. Graph. 8: 52-56, 1990.
21. Kabsch W. and Sander C., Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 2577-2637, 1983.
22. Wang J. and Springer T.A., Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunol. Rev. 163: 197-215, 1998.
23. Bork P., Holm L. and Sander C., The immunoglobulin fold. Structural classification, sequence patterns and common core. J. Mol. Biol. 242: 309-320, 1994.
24. Casasnovas J.M., Stehle T., Liu J.H., Wang J.H. and Springer T.A., A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc. Natl. Acad. Sci. USA 95: 4134-4139, 1998.
25. Casasnovas J.M., Springer T.A., Liu J.H., Harrison S.C. and Wang J.H., Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature 387: 312-315, 1997.
26. Vigers G.P., Andersen L.J., Gaffes P. and Brandhuber B.J., Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature 386: 190-194, 1997.
27. Holm L. and Sander C., Touring protein fold space with Dali/FSSP. Nucl. Acids Res. 26: 216-319, 1998.
28. Wang C.Y., Naka Y., Liao H., Oz M.C., Springer T.A., Gutierrez-Ramos J.C. and Pinsky D.J., Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation. Circ. Res. 82: 762-772, 1998.
29. Gahmberg C.G., Tolvanen M. and Kotovuori P., Leukocyte adhesion - structure and function of human leukocyte beta2-integrins and their cellular ligands. Eur. J. Biochem. 245: 215-232, 1997.
30. Shimaoka M., Xiao T., Liu J.H., Yang Y., Dong Y., Jun C.D., McCormack A., Zhang R., Joachimiak A., Takagi J., Wang J.H. and Springer T.A., Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112: 99-111, 2003.
31. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C. and Ferrin T.E., UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25: 1605-1612, 2004.
32. Barton G.J., Alscript - a tool to format multiple sequence alignments. Protein Engineering 6: 37-40, 1993.
33. Diamond M.S., Staunton D.E., Marlin S.D. and Springer T.A., Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65: 961-971, 1991.
34. Diamond M.S., Garcia-Aguilar J., Bickford J.K., Corbi A.L. and Springer T.A., The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell. Biol. 120: 1031-1043, 1993.
35. Vorup-Jensen T., Ostermeier C., Shimaoka M., Hommel U. and Springer T.A., Structure and allosteric regulation of the alpha X beta 2 integrin I domain. Proc. Natl. Acad. Sci. USA 100: 1873-1878, 2003.
36. Van der Vieren M., Le Trong H., Wood C.L., Moore P.F., St John T., Staunton D.E. and Gallatin W.M., A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity 3: 683-690, 1995.
37. Fortin J.F., Cantin R., Lamontagne G. and Tremblay M., Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71: 3588-3596, 1997.
38. Schubert U. and Strebel K., Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68: 2260-2271, 1994.
39. Schubert U., Antón L.C., Bacók I., Cox J.H., Bour S., Bennink J.R., Orlowski M., Strebel K. and Yewdell J.W., CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72: 2280-2288, 1998.
40. Bleijs D.A., Geijtenbeek T.B., Figdor C.G. and van Kooyk Y., DC-SIGN and LFA-1: a battle for ligand. Trends Immunol. 22: 457-463, 2001.
41. Arnaout M.A., Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol. Rev. 114: 145-180, 1990.
42. Yamaguchi N., Kubo C., Masuhiro Y., Lally E.T., Koga T. and Hanazawa S., Tumor necrosis factor alpha enhances Actinobacillus actinomycetemcomitans leukotoxin-induced HL-60 cell apoptosis by stimulating lymphocyte function-associated antigen 1 expression. Infect. Immun. 72: 269-276, 2004.
43. Cui W., Fan Y., Wu W., Zhang F., Wang J.Y. and Ni A.P., Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin. Infect. Dis. 37: 857-859, 2003.
44. Cloyd M.W., Chen J.J. and Wang I., How does HIV cause AIDS? The homing theory. Mol. Med. Today 6: 108-111, 2000.
45. Rösch P. and Willbold D., Is EIAV Tat protein a homeodomain? Science 272: 1672, 1996.
46. Willbold D., Metzger A., Sticht H., Voit R., Gallert K.C., Dank N., Bayer P., Krauss G., Goody R.S. and Rösch P., Equine infectious anemia virus transactivator is a homeodomain type protein. J. Mol. Biol. 277: 749-755, 1998.
47. Willbold D., Hoffmann S. and Rösch P. Secondary structure and tertiary fold of the human immunodeficiency virus protein U(Vpu) cytoplasmic domain in solution. Eur. J. Biochem. 245: 581-588, 1997.
48. González M.E. and Carrasco L. The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability. Biochemistry 37: 13710-13719, 1998.